Short-term baths with essential oils of Lippia sidoides,Ocimum gratissimum and Zingiber officinale influence blood parameters and survival of tambaqui (Colossoma macropomum) after infection with Aeromonas hydrophila

This study evaluated the effect of short-term baths with the essential oils (EOs) of Lippia sidoides, Ocimum gratissimum and Zingiber officinale on the survival, haematological, biochemical and histopathological parameters of native fish tambaqui (Colossoma macropomum), challenged with Aeromonas hydrophila. After challenge, the fish infected with A. hydrophila received therapeutic baths of 60 min, for five consecutive days. Treatments were as follows: challenged and not treated; challenged and treated with 10 mg L^?1 of gentamicin; challenged and treated with EO of L. sidoides (2.5 and 5.0 mg L^?1); challenged and treated with EO of O. gratissimum (5.0 and 10.0 mg L^?1); challenged and treated with Z. officinale EO (5.0 and 10.0 mg L^?1). The highest survival rates were 89.5% (fish treated with 5.0 mg L^?1 of O. gratissimum EO) and 75.0% (fish treated with 5.0 mg L^?1 of L. sidoides EO). Reductions in the haematocrit percentage, haemoglobin and erythrocyte number were observed in fish treated with L. sidoides and Z. officinale EOs compared with control fish. Mild to moderate damage to the liver tissue of fish after challenge and EO treatments were observed. It is suggested that baths containing O. gratissimum and L. sidoides EOs consist in a viable treatment to increase survival rates of C. macropomum infected with A. hydrophila.     

Bacillus subtilis CK3 used as an aquatic additive probiotics enhanced the immune response of crayfish Procambarus clarkii against newly identified Aeromonas veronii pathogen

To identify the aetiology of the disease outbreak in cultured Procambarus clarkii, a dominant bacteria strain from the diseased crayfish hepatopancreas was isolated. It was identified as Aeromonas veronii based on biochemical identification and 16S rDNA sequencing. The symptoms of artificially infected crayfish were similar to those of naturally infected P. clarkii. The A. veronii was sensitive to norfloxacin, ciprofloxacin, ceftazidime, cefuroxime and ceftriaxone antibiotics, while resistant to penicillin, ampicillin, oxacillin and piperacillin. Virulence genes such as the enterotoxin genes (act, alt and ast) and haemolytic toxin genes (hlyA and aerA) were detected. After A. veronii infection, the connections between some liver tubules disappeared, the vacuoles appeared in the brush border and the mitochondria were enlarged. The antagonistic action of previous identified B. subtilis CK3 against A. veronii was also detected. The supernatant of B. subtilis CK3 exhibits a significant bactericidal effect on A. veronii. After B. subtilis CK3 immersion, the antioxidant enzymes and immune-related enzyme activities in hepatopancreas were significantly higher than control. The accumulative mortality caused by infection of A. veronii can be significantly reduced by adding B. subtilis CK3 into the aquatic water. These results demonstrated that B. subtilis CK3 could act as a water additive to improve the immune response of P. clarkii against newly identified A. veronii. The present study will provide a new way for the prevention and control of crayfish bacterial diseases and also provide technical support for the healthy cultivation of P. clarkii.     

Furunculosis in Atlantic salmon (Salmo salar L.) is not readily controllable by bacteriophage therapy

The potential of bacteriophage therapy to control bacterial disease in farmed fish was tested using, as an example, furunculosis of Atlantic salmon, caused by Aeromonas salmonicida subsp. salmonicida.

In vivo testing with Atlantic salmon and rainbow trout (Oncorhynchus mykiss Walbaum) showed no adverse effects, with bacteriophage generally cleared within 96 h of administration by either intraperitoneal (i.p.) injection or oral in-feed.

Juvenile Atlantic salmon were administered a combination of bacteriophage O, R and B (1.9 × 10⁸ pfu fish^− 1) by i.p. injection, after they had been challenged with A. salmonicida subsp. salmonicida 78027, also by i.p. injection. The fish that were injected with bacteriophage immediately after challenge died at a significantly slower rate then those that were either not treated with bacteriophage, or treated 24 h post-challenge. However, the end result (100% mortality) was not affected.

In further experiments the effects of oral (1.88 × 10⁵ pfu g^− 1 fish^− 1 daily for 30 days), bath (1.04 × 10⁵ ml^− 1 daily for 30 days) and i.p. (6.25 × 10⁷ pfu fish^− 1) phage treatment to control furunculosis in experimentally infected Atlantic salmon were compared with antibiotherapy (treatment with 10 mg kg^− 1 bw^− 1 day^− 1 oxolinic acid for 10 days), using an indirect cohabitation challenge. No protection was offered by any of the bacteriophage treatments, compared to the positive challenge group, although significant protection was offered by the oxolinic acid treatment. Analysis of samples taken from the trials demonstrated that bacteriophage were correctly administered to the fish and, on occasion, were isolated from fish that had succumbed to furunculosis. It was also shown that bacteriophage resistant A. salmonicida subsp. salmonicida isolates could be recovered from mortalities in all the treatment groups.

The results suggest that, although there were no safety problems associated with the approach, furunculosis in Atlantic salmon is not readily controllable by application of bacteriophage.     

罗非鱼鱼种肠炎病的病理组织学及病原体的研究

本文从病理组织学的角度,研究了罗非鱼鱼种肠炎病的发生与发展,为其诊断与防治奠定了理论基础。结果表明,该病病原体为产气单胞菌。     

气单胞菌外膜蛋白基因工程疫苗的研究进展

就气单胞菌外膜蛋白的基因工程亚单位疫苗、DNA疫苗、重组活载体疫苗等基因工程疫苗的研究现状、免疫方式以及不足之处进行了综述,以期为气单胞菌疫苗研制提供参考。     

口服嗜水气单胞菌生物被膜疫苗的动物免疫试验

将热灭活的嗜水气单胞菌(Aeromonashydrophila)生物被膜(biofilm,BF)菌苗和浮游(freecell,FC)菌苗口服免疫小鼠和剑尾鱼,通过测定抗体效价、相对保护率、小鼠的淋巴细胞转化和肠道sIgA浓度,评价免疫效果。免疫20d后,BF菌苗组50尾剑尾鱼的相对保护率为68%;FC菌苗组为42%。BF菌苗组12只小鼠的相对保护率为70%;FC菌苗组为50%;对照组为17%。BF菌苗组小鼠外周血淋巴细胞转化率是7.28、FC菌苗组为3.87、对照组为2.36。BF菌苗组小鼠肠道sIgA浓度是1.22μg/mL;FC菌苗组为0.73μg/mL;对照组为0.465μg/mL。免疫30d后,小鼠的血清凝集抗体达到最高,BF组抗体达128:1,FC组为32:1,对照组为2:1。各组间差异显著(P<0.01)。结果表明,BF菌苗较FC菌苗能更有效地刺激机体的免疫系统,尤其是肠道淋巴组织的免疫应答,对剑尾鱼和小鼠具有较好的保护力。     

β-1,3-葡聚糖及其羧甲基衍生物对海湾扇贝免疫功能的影响

2003年3月和2004年4月，新疆某养殖场和西安灞桥区某养殖场的白斑狗鱼（Esox lucius Linnaeus）相继爆发“败血症”。从具有明显症状的濒死病鱼体表病灶和内脏组织分离得到12株优势菌株，经人工感染试验表明：其中10株分离菌为致病菌。对分离菌株进行形态、培养特征、生理生化试验鉴定，认为该病原菌为杀鲑气单胞菌史氏亚种（Aeromonas salmonida subsp．smith）。血清学试验表明各分离菌株具有相同的保护性抗原。组织病理学研究表明：患病狗鱼病灶肌纤维明显肿胀断裂，肌纤维束之间出现间隙；肝胰组织严重坏死，细胞核溶解消失，细胞浆崩解；肾小管绝大部分均已坏死，细胞破裂，胞浆呈红色团块状流失于管腔。脾脏细胞大量坏死，髓质内含铁血黄素沉积。代表菌株EL0304-1药敏试验结果为：对供试24种抗菌药物中的磺胺二甲嘧啶钠、磺胺二甲嚯唑钠等不敏感；庆大霉素、卡那霉素等中度敏感；对氧氟沙星、培氟沙星、新霉素等高度敏感。     

锦鲤暴发性出血症病原的研究

从患暴发性出症的锦鲤体内分离出2株细菌－052202和052203，应用细菌分离鉴定方法和法国Biomerieux FRC公司的API全自动微生物鉴定系统进行鉴定，结果显示：052202株为嗜麦芽窄食单胞菌（Stenotrophomonas maltophilia),052203株为温和气单胞（菌（Aeromonas sobria)。生物毒性试验的结果表明，温和气单胞菌可使健康锦鲤死亡，引起体表出血，肝，肾，脾，胆囊发生病变，有致病性；而嗜麦芽窄食单胞菌不引起健康锦鲤死亡，无致病性，28例药物的药敏试验结果表明，温和气单胞菌对新霉素，卡那霉素，庆大霉素，头孢噻吩，头孢曲松的头孢他啶的敏感性强或较强。     

Aeromonas sobria, a causative agent of disease in farmed perch, Perca fluviatilis L

Significant numbers of perch, Perca fluviatilis, raised on a pilot fish farm in Switzerland presented focal skin lesions on the lateral sides and fin rot. Mortality rates reached levels of up to 1% of the total fish on the farm per day. Virtually pure cultures of Aeromonas sobria were isolated from the liver, kidney, spleen and skin lesions of affected fish. Aeromonas sobria isolated from the farmed perch had a haemolytic effect on sheep and trout erythrocytes, autoaggregated, was cytotoxic for cultured fish cells and possessed genes involved in type III protein secretion. Experimental infection of naive perch with a single colony isolate of A. sobria from an affected farm fish resulted in the development of clinical signs identical to those seen on the farm. The results indicate that A. sobria can act as a primary pathogen of perch.     

Analysis of exotoxins produced by atypical isolates of Aeromonas salmonicida,by enzymatic and serological methods

In this study, exotoxins produced by 62 Aeromonas salmonicida strains and the bacterium Haemophilus piscium were analysed. Enzymatic assays, zymograms and serological detection were used to monitor secretion by bacterial strains of the previously described exotoxins P1, GCAT and AsaP1 and also the extracellular P2 metallo-gelatinase and a serine caseinase, which is different from the P1 protease and has not yet been characterized. Based on the results, the strains were divided into five groups. One comprised the type strains for A. salmonicida ssp. masoucida, H. piscium and 36% of the atypical isolates, and another, a type strain for A. salmonicida ssp. smithia together with 14% of the atypical isolates. A second type strain of A. salmonicida ssp. smithia was grouped with 8% of the atypical isolates. The largest group contained the type strains for A. salmonicida ssp. achromogenes and 38% of the atypical isolates. The type strains for A. salmonicida ssp. salmonicida were in the last group with all the four typical strains and 4% of the atypical isolates. The combination of zymogram and serological detection used is recommended as the most reliable method for characterizing A. salmonicida strains according to their exotoxin secretion.